c-LEcta, an innovative SHS portfolio company in the field of white biotechnology, reports in the Süddeutsche Zeitung on how its enzymes are used to produce new sweeteners based on the stevia plant. The sweeteners developed jointly with industrial partners already have FDA approval in the USA, where sugar substitutes are used in beverages and food. […]
The private equity news portal Unquote evaluates the effects of the new German Scheduling and Supply Act and refers to the opportunities and risks of the global medical technology market. Despite tougher regulations, experts do not expect an economic slowdown for the medical technology, life science and biotechnology industries. Dr. Andre Zimmermann, Partner at SHS […]
The concept with which the Graz-based company Tyromotion made it from university to world market leader is taken up in “die wirtschaft”. The SHS portfolio company from the SHS IV fund develops robotic and computer-supported therapy devices that support patients in rehabilitation after a stroke, multiple sclerosis or spinal cord injury. Tyromotion uses a playful […]
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information